Pine Labs Limited has made a significant investment of ₹63.99 crores in its wholly owned subsidiary BrokenTusk Technologies Private Limited (BTPL) through a rights issue subscription completed on January 23, 2026. The investment was disclosed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Investment Details

The transaction involved Pine Labs acquiring 4,83,01,886 equity shares of BTPL for a total consideration of ₹63,99,99,989.50 through cash payment. As BTPL remains a wholly owned subsidiary, there is no change in the shareholding percentage following this investment.

About BrokenTusk Technologies

BTTP was incorporated on September 19, 2018, under the Companies Act, 2013, as a private limited company. The subsidiary operates in the financial technology services sector, providing technology solutions that enable payment services for businesses. Companies can integrate with BTPL's technology solutions through APIs to offer various payment services, including bill payments and UPI payments.

Financial Performance Trajectory

BTTP has demonstrated consistent growth over the past three years, with turnover showing substantial year-over-year increases. The subsidiary's revenue growth reflects the expanding adoption of digital payment solutions in the Indian market.

Strategic Rationale

The investment aims to meet BTPL's working capital requirements and support further growth opportunities in the fintech sector. The transaction does not fall under related party transactions as per SEBI regulations, and no governmental or regulatory approvals were required for completion.

Regulatory Compliance

The disclosure was made by Company Secretary and Compliance Officer Neerav Mehta (Membership Number: A20949) to both BSE Limited (Scrip Code: 544606) and National Stock Exchange of India Limited (Symbol: PINELABS), ensuring full compliance with listing obligations and transparency requirements.

Pine labs Limited has announced its board meeting and earnings conference call schedule for the third quarter of fiscal year 2025-26, as communicated to stock exchanges on January 20, 2026. The company will present its financial performance for the quarter and nine months ended December 31, 2025.

Board Meeting and Financial Results

The Board of Directors meeting is scheduled for Wednesday, January 28, 2026, where directors will consider and approve the unaudited standalone and consolidated financial results. The meeting agenda includes reviewing the company's performance for both the quarter and nine-month period ended December 31, 2025, along with other business matters.

Investor Conference Call Details

Pine Labs Limited will host an investors and analysts conference call immediately following the board meeting to discuss the financial results. The call is designed to provide stakeholders with insights into the company's quarterly performance and address questions from the investment community.

Regulatory Compliance and Communication

The announcement was made pursuant to Regulation 29 and Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Pine Labs Limited has informed both BSE Limited and National Stock Exchange of India Limited about the scheduled board meeting and earnings call.

The company will publish the financial results in newspapers in accordance with Regulation 47 of the SEBI Listing Regulations. Additionally, all relevant information regarding the earnings call and financial results will be made available on the company's official website at www.pinelabs.com/investor-relations .

Contact Information

For further information or queries regarding the earnings call, investors and analysts can contact Arpit Khurana from the Investor Relations Team at investorrelations@pinelabs.com . The communication was signed by Neerav Mehta, Company Secretary and Compliance Officer, on January 20, 2026.